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The binding of influenza A virus hemagglutinin to its cell surface receptor, s-linked 5-N-acetylneuraminic acid (sialic acid), was studied in solution. 
The effect of structural modifications introduced into the N-acetyl group of the sialic acid on the binding was monitored by determining the 
dissociation constants by proton nuclear magnetic resonance (1H NMR) spectroscopy. Methyl c~-glycoside ofNothioacetylneuraminic ac d showed 
high, whereas the corresponding N-methylcarbamoylneuraminic acid exhibited relatively low binding affinity towards the hemagglutinin. 
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1. INTRODUCTION 
The process of adsorption of the influenza virus onto 
the surface of the host cell, prior to penetration by the 
viral genome into the cytoplasm, includes the interac- 
tion by one of the surface viral glycoproteins, hemag- 
glutinin, with the sialic acid residues bound to cell-sur- 
face glycoproteins or glycolipids [1]. The interest in a 
clarification of the molecular mechanisms by which 
hemagglutinin and sialic acid interact is twofold. First, 
it is important to know what chemical groups of hemag- 
glutinin are involved in this interaction and how this 
interaction can influence the physico-chemical events 
accompanying the penetration of the influenza virus 
into the cell; second, if a compound could be found 
which bound tightly to the region of the hemagglutinin 
molecule responsible for the interaction with the cell 
receptor, it would be possible, in theory at least, to 
block the adsorption of the influenza virus by the cell 
and thus to prevent infection. This would provide a 
rational approach to the chemotherapy of influenza in- 
fections. The obvious way to treat his problem is to use 
low molecular weight synthetic derivatives of sialic acid 
which can be considered to mimic receptor molecules 
[2,3]. 
*Corresponding author. Fax: (49) (228) 732 416. On leave from the 
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The binding of a variety of sialic acid derivatives to 
influenza virus and to isolated influenza virus hemag- 
glutinin has been studied using different physico-chemi- 
cal techniques, namely the inhibition of influenza virus 
adsorption on erythrocytes [4,5], competition studies 
using enzyme labelled fetuin [6], 1H NMR spectroscopy 
[7-9] and X-ray crystallography [10,11]. Sauter et al. 
[7,9] studied the effect of functional modifications of 
sialic acid on the binding constant. The removal of 
those functional groups which, according to the X-ray 
studies, are involved in the binding, resulted in reduced 
or abolished affinity. Other modifications had no or 
litte effect. None of the derivatives they studied showed 
significant binding affinity. 
We report here the ~H NMR analysis of the binding 
of further, modified sialic acids to hemagglutinin. The 
main purpose of this work was to find a substance of 
increased binding activity which would serve as a lead 
compound for potential inhibitors of influenza virus 
adsorption by the cell surface receptors. 
We screened the following compounds (in brackets is 
the name used throughout this paper). 
- methyl s-glycoside of N-acetylneuraminic acid (ace- 
tyMigand) 
methyl s-glycoside of N-thioacetylneuraminic acid 
(thioacetyl-ligand) 
- benzyl co-glycoside of N-propanoylneuraminic acid 
(propanoyl-ligand) 
-methy l  s-glycoside of N-acryloylneuraminic a id 
(acryloyl-ligand) 
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Fig. 1. 10% polyacrylamide g l electrophoresis of influenza virus and viral proteins in unreduced (A, without fl-mercaptoethanol) andreduced (B, 
with mercaptoethanol) conditions. Trace 1, virus; 2, BHA (after sucrose gradient); 3, BHA* (the first peak after column purification); 4, BHA* 
(the second peak after column purification). Abbreviations: HA (hemagglutinin), NA (neuraminidase), NP (nucleoprotein), M (matrix protein, HA~ 
(heavy chain of HA), HA 2 (light chain of HA), BHA 2 (bromelain-released HA2) , NAj (dimer of NA), NAm (monomer of NA). 
- methyl a-glycoside of N-thiopropanoylneuraminic 
acid (thiopropanoyl-ligand) 
- methyl a-glycoside of N-methylcarbamoylneuram- 
inic acid (methylcarbamoyl-ligand). 
2.  MATERIALS AND METHODS 
2.1. Hemagglutinin purification 
Hemagglutinin of serotype H3 was purified from the recombinant 
X-31 by a modification of the procedure of Brand and Skehel [12]. The 
hemagglutinin was released from the purified influenza virus with 
bromelain (Sigma, B-2252) under the following conditions: concentra- 
tion of the virus, 2 mg/ml; concentration f bromelain, 2 mg/ml (after 
clarification of the enzyme solution by low-speed centrifugation), in-
cubation at 35°C for 16 h in 0.1 M Tris-HC1 buffer (pH 7.2) in the 
presence of 0.05 M mercaptoethanol and 1 mM EDTA. After ul- 
tracentrifugation (Beckman rotor SW-65, 1 h, 10°C, 35,000 rpm) and 
concentration f the supernatant with a collodium bag concentrator 
(Schleicher and Schuell), the bromelain-released hemagglutinin 
(BHA) was isolated from the supernatant bydensity-gradient centrif- 
ugation using Beckmann rotor SW-41 (16 h, 10°C, 40,000 rpm) with 
a sucrose gradient of 5-20%. After fractionation ofthe gradient with 
a fraction collector the collected BHA peak was dialysed against 0.1 
M acetate buffer (pH 5.5) and was concentrated using a collodium bag 
concentrator. Purification of BHA from residual neuraminidase was 
achieved by using a Sepharose-sulfanilic acid column [13], passing the 
BHA preparation through the column at pH 5.5 (BHA*). Then BHA* 
was dialysed against a mixture of 0.02 M D20-phosphate buffer (pH 
7.2), 0.125 M sodium chloride and sodium azide (0.01%). Finally the 
BHA* was concentrated in a collodium bag concentrator. The concen- 
tration of the BHA* was determined by the following methods: 
Lowry, Bradford, bicinchoninic methods and measurement of the 
optical density at 280 nm. The purity of the BHA* was checked by 
polyacrylamide g l electrophoresis (see Fig. 1) and its structure was 
determined by circular dichroism (CD) measurements a  185 270 nm 
(a-helix, 29.4%; fl-structure, 18.0%; random coil, 52.6%). 
2.2. Ligands 
Methyl a-glycoside of N-acetylneuraminic acid was prepared from 
per-O-acetylated methyl N-acetylneuraminate via the corresponding 
2-chloro derivative. The propanoyMigand was synthesized byreaction 
of propanoic anhydride with benzyl a-glycoside of neuraminic acid 
which in turn was obtained by alkaline de-N-acetylation. Reaction of 
neuraminic acid methyl-a-glycoside with acryloyl chloride afforded 
the acryloyl-ligand. The detailed synthesis and properties of the thio- 
acetyl and the thiopropanoyl-ligands will be described elsewhere. 
2.3. Binding experiments 
When a ligand rapidly exchanges between a protein binding site and 
solvent, the observed chemical shifts (8ob~) and line widths (AVob,) of 
the various ligand resonances can differ from the shifts (5fr~e) and line 
widths (AVfre,) seen in the absence of protein. 
The dissociation constant, Kd can be determined as described by 
Kronis and Carver [13]. If the fraction of ligand bound to protein is 
small, Ka is given by either of the following equations: 
[L]roT = ([PlxoT/A~AS.~pp - Kd 
[L]xoT = ([P]7or/AAv)AAVBapp - K d 
where 
A5 = 5ob~ - 5f~oo 
A/ IV  = AVob s - -  AVf ree  
[P]ToT is the total concentration f protein binding sites. [L]roT is the 
totalligand concentration. ASBa andAAVBa are the apparent chem- 
. . . .  PP . PP , 
lcal shift and line-width changes for the hgand m the bound state. Kd 
can be determined from the y intercept in plots of [L]ToT versus I/A5 
or [L]Tor VS. I/AAv. When AAv values are to be determined, one 
must be certain that only changes due to the interaction with the 
protein are measured. Therefore the line width of the trimethylsilyl 
resonance of TSP (sodium(trimethylsilyl)proprionate) as n internal 
reference was also monitored and the normalised AAv values were 
calculated as follows: 
AAv = ( ,dv  H - AVTSP)prote i  n - -  (AV  H - -  / IVTsP) f ree  
2.4. NMR spectroscopy 
Ligands were prepared for NMR studies by DzO-exchange followed 
by lyophilization (three times). In order to perform D20-exchange of 
BHA the collodium bag containing the protein was placed in deuter- 
ated PBS buffer (pH 7.1; 0.15 M sodium chloride, 0.10 M sodium 
phosphate, sodium azide (0.01%)). Fresh buffer was used three times. 
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Fig. 2. 500 MHz ~H NMR spectra showing the thioacetyl methyl (singlet, left hand side), the H3, (triplet) resonances of the thioacetyl- ligand and 
the reference (TSP, right hand side) signal. See section 2 for details. 
The measurements were performed in deuterated PBS buffer (see 
above). Ligand concentration varied between 0.5 mM and 18 mM. 
BHA concentration was 23 ,uM or 53 ¢tM. IH NMR spectra were 
recorded by a Bruker AMX-500 spectrometer at 298 K. Depending 
on the ligand concentration, between 32 and 6144 scans were collected. 
Digital resolution was 0.05 Hz/point. The line widths and chemical 
shifts were determined using the standard econvolution programme 
of Bruker. TSP was used as an internal reference (see above). 
3. RESULTS AND DISCUSSION 
Fig. 2 shows a typical set of spectra measured on 
changing the concentrat ion of the ligand (thioacetyl- 
ligand). The perturbations in chemical shift and line 
width due to the interaction with hemagglutinin were 
different for the different resonances. On lowering the 
concentrat ion of the ligand the perturbations became 
larger, as a higher fraction of the l igand was bound. For  
quantitative analysis and the determination of Ka only 
well-resolved signals could be used which showed large 
chemical shift and/or line width changes, compared to 
experimental errors, over a wide range of l igand concen- 
tration. 
Measurable chemical shift changes were observed 
only for the methyl group resonances of the actyl, thio- 
acetyl, th iopropanoyl  group and for the acryloyl reso- 
Table I
Ligand Line Protein Kd (mM) 
analysed conc. 
(uM) 
Acetyl H3,x 23 1.5 
Acetyl 23 1.8 
Thioacetyl H3,x 23 0.1 
Thioacetyl 23 0.3 
Acryloyl 
Propanoyl 
Thiopropanoyl 
Methylcarbamoyl 
H3ax 51 14 
H3,x 23 0.5 
Methylene 23 2.1 
Methyl 23 0.7 
(propanoyl group) 
H3ax 23 1.5 
H5 23 2.1 
13 
23 1.8 Methyl 
(thiopropanoyl group) 
H3,x 23 25 
Methyl 23 23 
(methylcarbamoyl group) 
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Fig. 3. [L]ToT VS. 1/A# and [L]m T vs. I/AAv plots for the N- thioacetyl 
methyl resonance of the thioacetamido-group. 
nances. Analysis of chemical shift data indicates the 
same relative binding potency for the derivatives al- 
though the absolute values for the dissociation con- 
stants are different. 
Fig. 3 shows an example of the plots used for deter- 
mining the dissociation constants. Table I summarizes 
the K~ values obtained. As seen from the table the anal- 
ysis of different lines resulted in different K d values. The 
results were also different when chemical shifts or line 
widths were analysed. 
Although the Kd values obtained for the same ligand 
by the analysis of different lines are not the same, the 
difference between the binding affinity of the different 
compounds is clear and the data suggest that the thio- 
acetyl-ligand has higher activity towards the hemag- 
glutinin than any of the compounds so far studied by 
us and by others. The relatively low affinity of the meth- 
ylcarbamoyl igand is also unambiguous. 
For the first time a sialic acid glycoside monomer has 
been shown to possess a significantly higher affinity 
towards the influenza virus hemagglutinin than the nat- 
ural receptor and any of the compounds so far studied 
by us and by others. Obviously such compounds possess 
interesting potential for chemotherapeutic application. 
There is evidence that multivalent binding to opti- 
mally spaced surface carbohydrate pitopes signifi- 
cantly increases the receptor affinity of influenza viri- 
ons. Thus, oligosaccharides derived from equine and 
from human c~2-macroglobulin, which are similar in 
structure, have the same low affinity to hemagglutinin. 
However, equine c~2-macroglobulin containing multiple 
optimally spaced oligosaccharides is a high affinity re- 
ceptor, whereas human ~2-macroglobulin which 
spacing is not optimal, has a low affinity [14]. It will 
therefore be interesting to see if the binding affinity of 
the thioacetyl ligand and, thus, its potential as an inhib- 
itor of virus adsorption can be further increased by 
polymerization under appropriate conditions. 
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